Bionano Genomics, Inc. (BNGO)

USD 2.79

(-7.92%)

Net Debt Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual net debt in 2023 was 34.88 Million USD , up 430.36% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly net debt in 2024 Q2 was 6.13 Million USD , down -77.41% from previous quarter.
  • Bionano Genomics, Inc. reported annual net debt of 6.57 Million USD in 2022, up 147.4% from previous year.
  • Bionano Genomics, Inc. reported annual net debt of -13.87 Million USD in 2021, up 37.28% from previous year.
  • Bionano Genomics, Inc. reported quarterly net debt of 27.17 Million USD for 2024 Q1, down -22.11% from previous quarter.
  • Bionano Genomics, Inc. reported quarterly net debt of -24.42 Million USD for 2023 Q3, down -482.54% from previous quarter.

Annual Net Debt Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Net Debt of Bionano Genomics, Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 34.88 Million USD 430.36%
2022 6.57 Million USD 147.4%
2021 -13.87 Million USD 37.28%
2020 -22.12 Million USD -915.92%
2019 2.71 Million USD 136.18%
2018 -7.49 Million USD -231.28%
2017 5.7 Million USD 312.55%
2016 1.38 Million USD 0.0%

Peer Net Debt Comparison of Bionano Genomics, Inc.

Name Net Debt Net Debt Difference
bioAffinity Technologies, Inc. -1.24 Million USD 2906.431%
Aspira Women's Health Inc. -331 Thousand USD 10638.369%
Castle Biosciences, Inc. -83.53 Million USD 141.759%
Exact Sciences Corporation 1.94 Billion USD 98.211%
IDEXX Laboratories, Inc. 493.94 Million USD 92.938%
Intelligent Bio Solutions Inc. -5.43 Million USD 742.08%
iSpecimen Inc. -2.14 Million USD 1724.366%
Standard BioTools Inc. 46.5 Million USD 24.995%
Inotiv, Inc. 382.14 Million USD 90.872%
Psychemedics Corporation 334 Thousand USD -10343.713%
Prenetics Global Limited -43.33 Million USD 180.49%
RadNet, Inc. 1.14 Billion USD 96.963%
Star Equity Holdings, Inc. -15.33 Million USD 327.437%
Neuronetics, Inc. 2.79 Million USD -1147.122%
OpGen, Inc. 11.89 Million USD -193.326%
Exagen Inc. -12.77 Million USD 373.113%
CareDx, Inc -47.97 Million USD 172.707%
Check-Cap Ltd. -24.75 Million USD 240.903%
Twist Bioscience Corporation -192.4 Million USD 118.13%
Guardant Health, Inc. 220.22 Million USD 84.161%
Biodesix, Inc. 34.3 Million USD -1.676%
BioNexus Gene Lab Corp. -5.79 Million USD 701.835%
Precipio, Inc. -386 Thousand USD 9136.788%
Natera, Inc. -200.1 Million USD 117.432%
Fulgent Genetics, Inc. -82.56 Million USD 142.247%
Sera Prognostics, Inc. -2.02 Million USD 1825.124%
23andMe Holding Co. -141.37 Million USD 124.674%
OPKO Health, Inc. 230.68 Million USD 84.879%
Personalis, Inc. -8.02 Million USD 534.829%
Aclaris Therapeutics, Inc. -39.45 Million USD 188.416%
Applied DNA Sciences, Inc. -5.91 Million USD 689.817%
T2 Biosystems, Inc. 33.8 Million USD -3.174%
Neogen Corporation 735.62 Million USD 95.258%
Myriad Genetics, Inc. 88.1 Million USD 60.406%
ICON Public Limited Company 3.56 Billion USD 99.02%
NeoGenomics, Inc. 269.19 Million USD 87.042%
Star Equity Holdings, Inc. -15.33 Million USD 327.437%
MDxHealth SA 18.88 Million USD -84.707%
Prenetics Global Limited -43.33 Million USD 180.49%
Illumina, Inc. 1.21 Billion USD 97.127%
DarioHealth Corp. -7.54 Million USD 562.136%
ENDRA Life Sciences Inc. -2.43 Million USD 1529.881%
Medpace Holdings, Inc. -103.32 Million USD 133.759%
Mainz Biomed B.V. 349.85 Thousand USD -9870.416%
Trinity Biotech plc 63.73 Million USD 45.271%
Sotera Health Company 2.02 Billion USD 98.278%
bioAffinity Technologies, Inc. -1.24 Million USD 2906.431%